Dova Pharmaceuticals Inc (DOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 4,584 | 0 | 0 | 0 | 0 |
| Cost of Goods | 519 | N/A | N/A | N/A | N/A |
| Gross Profit | 4,065 | N/A | N/A | N/A | N/A |
| Operating Expenses | 23,592 | 13,677 | 9,169 | 9,611 | 5,198 |
| Operating Income | -19,008 | -13,677 | -9,169 | -9,611 | -5,198 |
| Interest Expense | 454 | 315 | 408 | 336 | 295 |
| Other Income | -195 | 222 | 276 | 224 | -14 |
| Pre-tax Income | -19,657 | -13,770 | -9,301 | -9,723 | -5,507 |
| Net Income Continuous | -19,657 | -13,770 | -9,301 | -9,723 | -5,507 |
| Net Income | $-19,657 | $-13,770 | $-9,301 | $-9,723 | $-5,507 |
| EPS Basic Total Ops | -0.70 | -0.52 | -0.39 | -0.38 | -0.32 |
| EPS Basic Continuous Ops | -0.70 | -0.52 | -0.38 | -0.38 | -0.32 |
| EPS Diluted Total Ops | -0.70 | -0.52 | -0.39 | -0.38 | -0.32 |
| EPS Diluted Continuous Ops | -0.70 | -0.52 | -0.38 | -0.38 | -0.32 |
| EPS Diluted Before Non-Recurring Items | -0.70 | -0.52 | -0.36 | N/A | N/A |
| EBITDA(a) | $-18,814 | $-13,674 | $-9,169 | $-9,611 | $-5,198 |